HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma

Oncotarget
Valli De ReMaurizio Mascarin

Abstract

In this study, we tested whether polymorphisms in human leukocyte antigen G (HLA-G) were associated with event-free survival (EFS) in pediatric Hodgkin's lymphoma (HL). We evaluated the association of HLA-G 3'-UTR polymorphisms with EFS in 113 pediatric HL patients treated using the AIEOP LH-2004 protocol. Patients with the +3027-C/A genotype (rs17179101, UTR-7 haplotype) showed lower EFS than those with the +3027-C/C genotype (HR= 3.23, 95%CI: 0.99-10.54, P=0.012). Female patients and systemic B symptomatic patients with the HLA-G +3027 polymorphism showed lower EFS. Multivariate analysis showed that the +3027-A polymorphism (HR 3.17, 95%CI 1.16-8.66, P=0.025) was an independent prognostic factor. Immunohistochemical analysis showed that HL cells from patients with the +3027-C/A genotype did not express HLA-G. Moreover, HLA-G +3027 polymorphism improved EFS prediction when added to the algorithm for therapeutic group classification of pediatric HL patients. Our findings suggest HLA-G +3027 polymorphism is a prognostic marker in pediatric HL patients undergoing treatment according to LH-2004 protocol.

References

Apr 1, 1992·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M BoiocchiF Menestrina
Jun 1, 1983·Journal of Immunogenetics·R ConteP Zucchelli
May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·P PaulE D Carosella
Jan 9, 2004·Advances in Immunology·Edgardo D CarosellaNathalie Rouas-Freiss
Jan 27, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Joël LeMaoultEdgardo D Carosella
Oct 21, 2005·Human Molecular Genetics·Zheng TanCarole Ober
Nov 17, 2005·Cancer Research·Nathalie Rouas-FreissEdgardo D Carosella
Feb 24, 2007·The EMBO Journal·Julien CaumartinJoel LeMaoult
Feb 6, 2008·Trends in Immunology·Edgardo D CarosellaNathalie Rouas-Freiss
Mar 24, 2010·Proceedings of the National Academy of Sciences of the United States of America·Henrik HjalgrimRuth F Jarrett
Nov 26, 2010·Cellular and Molecular Life Sciences : CMLS·Eduardo A DonadiPhilippe Moreau
Mar 5, 2011·Molecular Carcinogenesis·Claudia M MonroyRanda El-Zein
May 31, 2011·Molecular Biology and Evolution·Erick C CastelliEduardo A Donadi
Jan 31, 2012·Journal of the National Cancer Institute·Kevin Y UrayamaJames D McKay
Mar 24, 2012·Leukemia·A NajiN Rouas-Freiss
Jul 19, 2012·PloS One·Xin HuangAnke van den Berg
Dec 12, 2012·Tissue Antigens·M De ZorziV De Re
Nov 8, 2013·British Journal of Cancer·E C M ZeestratenP J K Kuppen
May 7, 2014·Journal of Immunology Research·Nathalie Rouas-FreissEdgardo D Carosella
May 20, 2014·Journal of Immunology Research·Laurence AmiotMichel Samson
Jun 16, 2015·Advances in Immunology·Edgardo D CarosellaJoel LeMaoult
Oct 16, 2015·Proceedings of the National Academy of Sciences of the United States of America·Tamara TilburgsJack L Strominger
Dec 3, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Piero FarruggiaUNKNOWN AIEOP (Italian Association of Pediatric Hematology and Oncology) and Hodgkin Lymphoma working group
Jun 29, 2016·European Journal of Histochemistry : EJH·G CaocciG La Nasa

❮ Previous
Next ❯

Citations

Oct 5, 2019·Journal of Clinical Medicine·Valli De ReMaurizio Mascarin

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
genotyping

Software Mentioned

Assign SBT
SKDM
ARLEQUIN

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved